Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

News Focus

LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)

Bullboard - Stock Discussion Forum Pfizer Inc PFE

Alternate Symbol(s): N.PFE

Healthcare

Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the... see more

Add To Watchlist

Bullboard (NYSE:PFE)

View:

Post by ecolo101on Jun 14, 2024 8:00am

Today we get paid 0.42$

It should get in the account or 1.5% on the quarter for 6% a year. glta

(0)
•••

Post by PressReleaseon Jun 14, 2024 3:00am

New Press Release - ELREXFIO(TM) Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory Multiple Myeloma

Patients in MagnetisMM-3 demonstrated a median overall survival (OS) of 24.6 months, with median progression-free survival (PFS) of 17.2 months Pfizer Inc. (NYSE: PFE) today announced detailed overall survival (OS) results from the Phase 2 MagnetisMM-3 study of ELREXFIO™ (elranatamab-bcmm) in...read article.

Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million

posted Nov 21, 2024 9:00am by Innocan Pharma Corp

"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more

Comment by jboom70on Jun 13, 2024 11:39am

RE:This short seems to have the hand

It's the laggered in the sector. At some point it will turn off this bottom.

Discussion

(0)
•••

Post by PressReleaseon Jun 12, 2024 4:30pm

New Press Release - Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with Duchenne Muscular Dystrophy

Pfizer Inc. (NYSE: PFE) today announced that CIFFREO, a Phase 3 global, multicenter, randomized, double-blind, placebo-controlled study evaluating the investigational mini-dystrophin gene therapy, fordadistrogene movaparvovec, in ambulatory patients with Duchenne muscular dystrophy (DMD) did not...read article.

Post by ecolo101on Jun 12, 2024 12:36pm

This short seems to have the hand

With the Dow and all markets going up , PFE is going down.... how low Can they force it down? A big question... it push the dividend up on a percentage basis , at one point some investors will get on ...more

Discussion

Post by ecolo101on Jun 10, 2024 12:25pm

Post by PressReleaseon Jun 05, 2024 4:05pm

New Press Release - Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608

Initial triplet combination of RLY-2608 + atirmociclib + fulvestrant to be evaluated in patients with PI3Ka-mutated HR+/HER2- metastatic breast cancer; initiation planned by end of 2024 CAMBRIDGE, Mass., June 05, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage...read article.

Post by ecolo101on Jun 05, 2024 12:45pm

Daily Trading swing

Are getting smaller by the day indicating that stock price is getting higher for sure... We will get above the 200 Mda in the next few weeks... glta dyodd